The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Novo Nordisk’s oral Wegovy pill for chronic weight loss is under FDA review. If approved, it would be the first oral GLP-1 ...

The FDA will decide whether to approve a once-daily, 25 mg oral formulation of semaglutide (Wegovy) by the end of 2025. If ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

This time next year, you may be swapping your GLP-1 injections for easier and as-effective oral weight-loss medication. It's ...

Last year, more than 16 million people googled 'semaglutide' - sold under the brand names Wegovy and Ozempic - as demand for ...

Starting July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial template ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

The “Vanderpump Rules” alum added that she will “absolutely” do weight-loss injections ... proposal pictures with her followers at the time, gushing, “out of the all the fish in the ...

The Valley star Kristen Doute discussed how she would like to lose weight after she gives birth to her and Luke Broderick’s first child, and she’s not ruling out the use of weight loss drugs.

Ozempic (semaglutide ... weight in that time. Ozempic is not approved for weight loss or weight management, but doctors may prescribe it off-label for weight management. (With off-label use, ...